Table 1.
Clinical Information for Five Paired Neuroblastoma Samples Used for circRNA Sequencing
| Patients | Age | Gender | INSS Stage | Risk Group | FH/UH | MYCN Status | Size | LDH | NSE | SF |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 9 months | Male | I | Low | FH | NA | 33*24*31mm | 469 | 37.3 | 205 |
| 2 | 3 months | Female | I | Low | FH | NA | 33*33*32mm | 343 | 20.8 | 108 |
| 3 | 6 months | Male | IVs | Inter | FH | NA | 22*20*18mm | 250 | 24.3 | 228 |
| 4 | 3 months | Male | IVs | Inter | FH | NA | 43*42*31mm | 479 | 73.3 | 51 |
| 5 | 2 months | Female | I | Low | FH | NA | 41*39*29mm | 581 | 19.5 | 285 |
Notes: The normal value of LDH is from 180 to 430 IU/L; the normal value of NSE is less than 16.3 ng/mL; the normal value of SF is from 26.08 to 287.63 ng/mL.
Abbreviations: INSS, International Neuroblastoma Staging System; Inter, intermediate; FH, favorable histology group; UH, unfavorable histology group; NA, not amplified; LDH, lactate dehydrogenase; NSE, neuron specific enolase; SF, serum ferritin.